WP
TYRA icon

Woodline Partners’s Tyra Biosciences TYRA Stock Holding History

Woodline Partners’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.5M Buy
+301,040
New +$9.75M 0.04% 475
2025
Q3 		– Sell
-100,108
Closed -$958K – 1054
2025
Q2 		$958K Hold
100,108
– – 0.01% 808
2025
Q1 		$931K Buy
+100,108
New +$1.3M 0.01% 770
2024
Q4 		– Sell
-55,866
Closed -$1.31M – 1004
2024
Q3 		$1.31M Sell
55,866
-32,790
-37% -$688K 0.01% 496
2024
Q2 		$1.42M Buy
+88,656
New +$1.53M 0.01% 442
2023
Q4 		– Sell
-410,435
Closed -$5.65M – 660
2023
Q3 		$5.65M Hold
410,435
– – 0.07% 302
2023
Q2 		$6.99M Hold
410,435
– – 0.08% 255
2023
Q1 		$6.6M Buy
410,435
+111,419
+37% +$1.33M 0.09% 252
2022
Q4 		$2.27M Buy
299,016
+57,917
+24% +$410K 0.03% 460
2022
Q3 		$2.12M Sell
241,099
-48,073
-17% -$440K 0.03% 449
2022
Q2 		$2.07M Buy
289,172
+23,011
+9% +$183K 0.03% 416
2022
Q1 		$2.85M Buy
266,161
+1,416
+0.5% +$16.8K 0.05% 332
2021
Q4 		$3.73M Sell
264,745
-101,290
-28% -$2.01M 0.05% 326
2021
Q3 		$6.44M Buy
+366,035
New +$7M 0.11% 224

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Woodline Partners's TYRA Position: Q1 2026 in Review

Woodline Partners opened a new position in Tyra Biosciences (TYRA) in Q1 2026: 301,040 shares worth $11.5M. The stake represents 0.04% of the portfolio and ranks #475 among its holdings. This is a return to the name: Woodline Partners previously reported a position in TYRA as recently as Q2 2025.

Woodline Partners first reported a position in TYRA in Q3 2021 and has held it in 14 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Woodline Partners held 301,040 shares of Tyra Biosciences worth $11.5M as of Q1 2026.
  • Tyra Biosciences was a new Woodline Partners position in Q1 2026.
  • Tyra Biosciences made up 0.04% of Woodline Partners's portfolio in Q1 2026, its #475 holding.
  • Woodline Partners first reported a position in Tyra Biosciences in Q3 2021 and has held it in 14 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.